Abstract
Background Primary mediastinal germ cell tumors (PMGCT) are rare and high-grade malignant tumors. Mainstay treatment for PMGCT is systemic chemotherapy, and salvage surgery for residual tumor is considered in patients with normalized tumor makers. However, survival benefit of salvage surgery for persistent positive-marker patients remains unclear. The purpose is to clarify the outcome of salvage surgery for PMGCT.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
